RIL
IMNM icon

Rothschild Investment LLC’s Immunome IMNM Stock Holding History

Rothschild Investment LLC’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24K Hold
200
– – ﹤0.01% 2383
2026
Q1 		$4.37K Hold
200
– – ﹤0.01% 2125
2025
Q4 		$4.3K Buy
200
+5
+3% +$88 ﹤0.01% 1973
2025
Q3 		$2.28K Sell
195
-55
-22% -$547 ﹤0.01% 2151
2025
Q2 		$2.33K Buy
250
+150
+150% +$1.23K ﹤0.01% 1971
2025
Q1 		$673 Buy
100
+40
+67% +$384 ﹤0.01% 2517
2024
Q4 		$637 Sell
60
-15
-20% -$181 ﹤0.01% 2442
2024
Q3 		$1.1K Buy
75
+65
+650% +$924 ﹤0.01% 2105
2024
Q2 		$121 Buy
+10
New +$156 ﹤0.01% 2667

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Rothschild Investment LLC's IMNM Position: Q2 2026 in Review

Rothschild Investment LLC held its Immunome (IMNM) position steady in Q2 2026 at 200 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.

Rothschild Investment LLC first reported a position in IMNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.37K in Q1 2026. 55 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Rothschild Investment LLC held 200 shares of Immunome worth $4.24K as of Q2 2026.
  • Rothschild Investment LLC left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2383 holding.
  • Rothschild Investment LLC first reported a position in Immunome in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Immunome position peaked at $4.37K in Q1 2026.
  • 55 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.